Laura Cancedda
Inventor
Stats
- 1 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 5 US Applications Filed
- 3 Total Citation Count
- Jul 11, 2022 Most Recent Filing
- May 10, 2012 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| CONSIGLIO NAZIONALE DELLE RICERCHE | 1
| 2012
|
| B&A THERAPEUTICS | 2
| 2014
|
| FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA | 1
2 | 2012
2014 |
Inventor Addresses
| Address | Duration |
|---|---|
| Genoa, IT | Nov 21, 17 - Aug 30, 22 |
| Genova, IT | Mar 06, 14 - Dec 01, 22 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| A61N: | ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY | 1 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2022/0380,807 | 2022 | METHOD FOR REDUCING THE EXPRESSION OF NKCC1 IN A SUBJECT | 0 |
| 11427836 | 2022 | Method for reducing the expression of NKCC1 in a subject | 0 |
| 2022/0184,008 | 2022 | MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION | 0 |
| 2021/0130,847 | 2021 | METHOD FOR REDUCING THE EXPRESSION OF NKCC1 IN A SUBJECT | 0 |
| 9822368 | 2017 | Modulators of intracellular chloride concentration for treating down syndrome | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.